News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
463,948 Results
Type
Article (25666)
Company Profile (152)
Press Release (438126)
Multimedia
Podcasts (68)
Webinars (16)
Section
Business (128635)
Career Advice (1020)
Deals (20904)
Drug Delivery (68)
Drug Development (48409)
Employer Resources (84)
FDA (11434)
Job Trends (9398)
News (211981)
Policy (18094)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (6)
Academia (1941)
Accelerated approval (28)
ADA (26)
Adcomms (6)
Allergies (122)
Alliances (38942)
ALS (106)
Alzheimer's disease (1118)
Antibody-drug conjugate (ADC) (365)
Approvals (11830)
Artificial intelligence (659)
ASCO (162)
Autoimmune disease (231)
Automation (53)
Bankruptcy (153)
Best Places to Work (7998)
BIOSECURE Act (8)
Biosimilars (109)
Biotechnology (113)
Bladder cancer (99)
Brain cancer (51)
Breast cancer (554)
Cancer (4017)
Cardiovascular disease (251)
Career advice (865)
Career pathing (18)
CAR-T (293)
CDC (50)
Celiac Disease (1)
Cell therapy (743)
Cervical cancer (43)
Clinical research (40961)
Collaboration (1798)
Company closure (1)
Compensation (399)
Complete response letters (26)
COVID-19 (1929)
CRISPR (114)
C-suite (797)
Cystic fibrosis (105)
Data (5491)
Decentralized trials (2)
Denatured (31)
Depression (69)
Dermatology (53)
Diabetes (387)
Diagnostics (5728)
Digital health (55)
Diversity (9)
Diversity, equity & inclusion (17)
Drug discovery (277)
Drug pricing (58)
Drug shortages (10)
Duchenne muscular dystrophy (143)
Earnings (48330)
Editorial (36)
Employer branding (10)
Employer resources (75)
Events (67102)
Executive appointments (761)
FDA (14150)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (18)
Funding (1333)
Gene editing (238)
Generative AI (56)
Gene therapy (550)
GLP-1 (491)
Government (2803)
Grass and pollen (3)
Guidances (279)
Healthcare (12269)
Hematology (95)
HIV (51)
Huntington's disease (29)
IgA nephropathy (67)
Immunology and inflammation (144)
Immuno-oncology (63)
Indications (133)
Infectious disease (2213)
Inflammatory bowel disease (134)
Inflation Reduction Act (7)
Influenza (132)
Intellectual property (225)
Interviews (146)
IPO (9242)
IRA (21)
Job creations (1721)
Job search strategy (740)
JPM (26)
Kidney cancer (8)
Labor market (41)
Layoffs (214)
Leadership (15)
Legal (3336)
Liver cancer (71)
Longevity (27)
Lung cancer (467)
Lymphoma (282)
Machine learning (55)
Management (33)
Manufacturing (814)
MASH (86)
Medical device (12405)
Medtech (12552)
Mergers & acquisitions (12526)
Metabolic disorders (789)
mRNA (192)
Multiple sclerosis (107)
NASH (7)
Neurodegenerative disease (264)
Neuropsychiatric disorders (39)
Neuroscience (1975)
Neurotech (1)
NextGen: Class of 2026 (4230)
Non-profit (2225)
Now hiring (19)
Obesity (286)
Opinion (158)
Ovarian cancer (167)
Pain (168)
Pancreatic cancer (216)
Parkinson's disease (240)
Partnered (20)
Patents (454)
Patient recruitment (501)
Peanut (45)
People (39425)
Pharmaceutical (26)
Pharmacy benefit managers (16)
Phase 1 (15501)
Phase 2 (17723)
Phase 3 (11957)
Pipeline (6432)
Policy (175)
Postmarket research (1074)
Preclinical (7174)
Press Release (67)
Prostate cancer (203)
Psychedelics (15)
Radiopharmaceuticals (264)
Rare diseases (639)
Real estate (3746)
Recruiting (36)
Regulatory (15586)
Reports (24)
Research institute (1869)
Resumes & cover letters (196)
Rett syndrome (34)
RNA editing (20)
RSV (61)
Schizophrenia (70)
Series A (231)
Series B (163)
Service/supplier (6)
Sickle cell disease (84)
Special edition (5)
Spinal muscular atrophy (102)
Sponsored (33)
Startups (2863)
State (2)
Stomach cancer (5)
Supply chain (74)
Tariffs (25)
The Weekly (35)
Vaccines (841)
Venture capital (67)
Weight loss (123)
Women's health (89)
Worklife (5)
Date
Today (103)
Last 7 days (389)
Last 30 days (1891)
Last 365 days (19110)
2026 (9292)
2025 (19312)
2024 (23312)
2023 (27104)
2022 (36745)
2021 (39116)
2020 (36635)
2019 (30705)
2018 (23345)
2017 (22293)
2016 (21168)
2015 (24726)
2014 (18544)
2013 (15530)
2012 (16525)
2011 (16912)
2010 (15246)
Location
Africa (487)
Alabama (82)
Alaska (6)
Arizona (247)
Arkansas (12)
Asia (30204)
Australia (5303)
California (8432)
Canada (2307)
China (988)
Colorado (384)
Connecticut (403)
Delaware (237)
Europe (63300)
Florida (1427)
Georgia (315)
Hawaii (4)
Idaho (37)
Illinois (726)
India (59)
Indiana (395)
Iowa (10)
Japan (449)
Kansas (117)
Kentucky (30)
Louisiana (40)
Maine (25)
Maryland (1194)
Massachusetts (6018)
Michigan (341)
Minnesota (552)
Mississippi (6)
Missouri (124)
Montana (31)
Nebraska (17)
Nevada (69)
New Hampshire (89)
New Jersey (2494)
New Mexico (26)
New York (2049)
North Carolina (1131)
North Dakota (10)
Northern California (4030)
Ohio (262)
Oklahoma (19)
Oregon (26)
Pennsylvania (1719)
Puerto Rico (23)
Rhode Island (42)
South America (663)
South Carolina (80)
South Dakota (1)
Southern California (3513)
Tennessee (147)
Texas (1328)
United States (30943)
Utah (262)
Vermont (1)
Virginia (179)
Washington D.C. (32)
Washington State (775)
West Virginia (4)
Wisconsin (117)
Wyoming (1)
463,948 Results for "human metabolome technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit
May 27, 2026
·
6 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
February 17, 2026
·
5 min read
Press Releases
Sensome Announces Positive First-in-Human Study Results for In Situ Tumor Detection Technology for Lung Cancer
May 19, 2026
·
5 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Press Releases
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
May 20, 2026
·
3 min read
Press Releases
Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
April 16, 2026
·
4 min read
Press Releases
GeneTex Formalizes Collaboration with the Human Protein Atlas
May 5, 2026
·
3 min read
Press Releases
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
BioMark Comprehensive Metabolomics Assay Selected as Top Canadian Innovation for the CTS Beaver Den Innovation Award
April 14, 2026
·
4 min read
Press Releases
Metabolon Appoints Celia Reyes as Vice President of Human Resources
January 15, 2026
·
3 min read
1 of 46,395
Next
